Table 1.
Patients’ characteristics in Control and Covid groups.
| N = 185 | Control group | Covid group | χ2 | |
|---|---|---|---|---|
| N = 92 | N = 93 | p-value | ||
| N (%) | N (%) | |||
| Age | (mean ± SD) | 53.9 ± 18.0 | 56.1 ± 17.6 | 0.389* |
| Gender | M F |
60 (65.2) 32 (34.8) |
53 (57.0) 40 (43.0) |
0.251 |
| Educational level | Until first level of secondary school Equal or upper than second level of secondary school |
31 (37.8) 51 (62.2) |
26 (31.0) 58 (69.0) |
0.353 |
| Occupational status | No Yes |
45 (54.9) 37 (45.1) |
43 (51.2) 41 (48.8) |
0.634 |
| Civil status | Single/divorced/widowed Married/cohabiting |
33 (41.3) 47 (58.8) |
34 (43.0) 45 (57.0) |
0.819 |
| Sons | No Yes |
17 (30.9) 38 (69.1) |
20 (32.3) 42 (67.7) |
0.876 |
| Type of facility where diagnosis was made | Public Privat or private + public |
39 (72.2) 15 (27.8) |
52 (74.3) 18 (25.7) |
0.797 |
| Institution where diagnosis was made | Elsewhere Our institution |
13 (14.9) 74 (85.1) |
22 (24.4) 68 (75.6) |
0.113 |
| Type of first treatment | Chemotherapy alone Radiotherapy alone Surgery Chemoradiotherapy Electrochemotherapy Best supportive care Follow-up |
27 (30.7) 5 (5.7) 46 (52.3) 2 (2.2) 1 (1.1) 0 (0.0) 7 (8.0) |
32 (34.8) 0 (0.0) 47 (51.1) 2 (2.2) 0 (0.0) 2 (2.2) 9 (9.8) |
0.168 |
| Extension of the disease | Localized Metastatic |
76 (83.5) 15 (16.5) |
81 (88.0) 11 (12.0) |
0.380 |
| Hystotype | Soft tissue sarcoma Bone sarcoma Benign muscoloscheletal aggressive disease Gastrointestinal stromal tumor Kaposi sarcoma |
58 (63.0) 19 (20.7) 9 (9.8) 2 (3.3) 3 (3.3) |
62 (66.7) 22 (23.7) 6 (6.5) 2 (2.2) 1 (1.1) |
0.709 |
*Student’s t-test.